Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2026-03-11 @ 3:04 AM
Study NCT ID:
NCT03911193
Status:
UNKNOWN
Last Update Posted:
2019-04-11
First Post:
2019-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation
Sponsor:
Fondazione Ricerca Traslazionale
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CABinMET
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None